Principles of Treatment for Type II Respiratory Failure
Respiratory failure is a severe impairment of respiratory function caused by various etiologies, resulting in decreased arterial partial pressure of oxygen (PaO₂), with or without an elevated partial pressure of carbon dioxide (PaCO₂), and associated pathophysiological disturbances.
Respiratory failure characterized by hypoxemia accompanied by hypercapnia is termed Type II respiratory failure.
The primary therapeutic principles for Type II respiratory failure include the following three major aspects:
1. Control and elimination of the underlying causes of respiratory failure. The most common clinical cause is chronic obstructive pulmonary disease (COPD); initial management therefore includes antimicrobial therapy, bronchodilators, and antispasmodics to relieve airway obstruction and bronchospasm, thereby optimizing ventilation.
2. Improvement of ventilation and gas exchange. Oxygen therapy is the most commonly employed intervention in clinical practice. For Type II respiratory failure, low-flow oxygen supplementation is used, typically maintaining an inspired oxygen concentration of no more than 35%.
3. Support and restoration of vital organ function. Type II respiratory failure frequently induces pathophysiological changes affecting multiple organ systems—including the gastrointestinal and nervous systems. Prompt and effective treatment of hypoxia leads to functional improvement across these critical systems.